OFDT Documentation

  • Recherche
    • Recherche simple
    • Périodiques
    • Publications OFDT
    • Textes législatifs
    • Nos dernières publications
  • Sélections
    • Usages de drogues à l’adolescence
    • Usages de drogues féminins
    • Drogues et sécurité routière
    • Addictions en milieu professionnel
    • Addictions en milieu carcéral
  • À propos
    • Présentation
    • Contact
Aide

Rechercher

Aide

Recherche avancée

Périodiques

Portail documentaire

  • A-
  • A
  • A+

Site OFDT

Historique

Accès réservé à l'OFDT et ses partenaires



Mot de passe oublié ?
  • Recherche
    • Recherche simple
    • Périodiques
    • Publications OFDT
    • Textes législatifs
    • Nos dernières publications
  • Sélections
    • Usages de drogues à l’adolescence
    • Usages de drogues féminins
    • Drogues et sécurité routière
    • Addictions en milieu professionnel
    • Addictions en milieu carcéral
  • À propos
    • Présentation
    • Contact

Rechercher

Aide

Recherche avancée

Périodiques

  1. Accueil
  2. Retour
Addiction, Vol.112, n°12 - December 2017
Ajouter à la sélection Ajouter à la sélection
Lien externe Lien externe
Bulletin de Périodique
Addiction , Vol.112, n°12 - December 2017
Paru le : 01/12/2017
Année : 2017
Page(s) : 2081-2280
Langue(s) : Anglais

Note de contenu :

CONTENTS:
- Why we should conduct research in collaboration with people who use alcohol and other drugs [Editorial]. Neale J., Bouteloup A., Getty M., Hogan C., Lennon P., Mc Cusker M., et al., p. 2084-2085.
- Precision medicine and pharmacogenetics: what does oncology have that addiction medicine does not? [Addiction debate]. Kranzler H.R., Smith R.V., Schnoll R., Moustafa A., Greenstreet-Akman E., p. 2086-2094.
- Challenges the addiction field must overcome to avert being the Cinderella of medicine. Lingford-Hughes A., p. 2095-2096.
- Precision medicine in addiction research: where has the time gone? Oliver J.A., McClernon F.J., p. 2096-2097.
- The experience of initiating injection drug use and its social context: a qualitative systematic review and thematic synthesis. Guise A., Horyniak D., Melo J., McNeil R., Werb D., p. 2098-2111.
- Who achieves low risk drinking during alcohol treatment? An analysis of patients in three alcohol clinical trials. Witkiewitz K., Pearson M.R., Hallgren K.A., Maisto S.A., Roos C.R., Kirouac M., et al., p. 2112-2121.
- Commentary on Witkiewitz et al. (2017): Abstinence or moderation - a choice for whom and why? Storbjörk J., p. 2122-2123.
- Heavy alcohol consumption increases the risk of active tuberculosis in Taiwanese adults: a nation-wide population-based cohort study. Yen Y.-F., Hu H.-Y., Lee Y.-L., Ku P.-W., Chuang P.-H., Lai Y.-J., et al., p. 2124-2131.
- Self-reported cognitive scales in a US National Survey: reliability, validity, and preliminary evidence for associations with alcohol and drug use. Aharonovich E., Shmulewitz D., Wall M.M., Grant B.F., Hasin D.S., p. 2132-2143.
- Structural neuroimaging correlates of alcohol and cannabis use in adolescents and adults. Thayer R.E., YorkWilliams S., Karoly H.C., Sabbineni A., Ewing S.F., Bryan A.D., et al., p. 2144-2154.
- A pilot randomized clinical trial testing integrated 12-Step facilitation (iTSF) treatment for adolescent substance use disorder. Kelly J.F., Kaminer Y., Kahler C.W., Hoeppner B., Yeterian J., Cristello J.V., et al., p. 2155-2166.
- Variation in cannabis potency and prices in a newly legal market: evidence from 30 million cannabis sales in Washington state. Smart R., Caulkins J.P., Kilmer B., Davenport S., Midgette G., p. 2167-2177.
- Potency increase, product development and marijuana marketing in times of legalization. Carlini B.H., p. 2178-2179.
- The need for better marijuana sales data. Williams J., Banta-Green C., Burgard D., p. 2179-2180.
- Response to Commentaries: new data sources for understanding cannabis markets. Smart R., Caulkins J.P., Kilmer B., Davenport S., Midgette G., p. 2180-2181.
- Associations between anhedonia and marijuana use escalation across mid-adolescence. Leventhal A.M., Cho J., Stone M.D., Barrington-Trimis J.L., Chou C.-P., Sussman S.Y., et al., p. 2182-2190.
- Rates, characteristics and circumstances of methamphetamine-related death in Australia: a national 7-year study. Darke S., Kaye S., Duflou J., p. 2191-2201.
- What is the real distribution of methamphetamine-related causes of death? Kuo C.-J., Chen C.-C., p. 2202-2203.
- Why methamphetamine-related deaths need more attention. McKetin R., p. 2203-2204.
- Methamphetamine-related death is an under-addressed public health problem. Darke S., Kaye S., Duflou J., p. 2204-2205.
- Mapping medical marijuana: state laws regulating patients, product safety, supply chains and dispensaries, 2017. Klieger S.B., Gutman A., Allen L., Pacula R.L., Ibrahim J.K., Burris S., p. 2206-2216.
- A free ride? An analysis of the association of casino bus tours and problem gambling among older adults. van der Maas M., Mann R.E., Matheson F.I., Turner N.E., Hamilton H.A., McCready J., p. 2217-2224.
- Commentary on van der Maas et al. (2017): Going where the action is. Markham F., Young M., p. 2225-2226.
- Accuracy of self-reported smoking abstinence in clinical trials of hospital-initiated smoking interventions. Scheuermann T.S., Richter K.P., Rigotti N.A., Cummins S.E., Harrington K.F., Sherman S.E., et al., p. 2227-2236.
- Effectiveness of intensive practice nurse counselling versus brief general practitioner advice, both combined with varenicline, for smoking cessation: a randomized pragmatic trial in primary care. van Rossem C., Spigt M., Viechtbauer W., Lucas A.E.M., van Schayck O.C.P., Kotz D., p. 2237-2247.
- The association between personal income and smoking among adolescents: a study in six European cities. Perelman J., Alves J., Pfoertner T.-K., Moor I., Federico B., Kuipers M.A.G., et al., p. 2248-2256.
- Setting research priorities in tobacco control: a stakeholder engagement project. Lindson N., Richards-Doran D., Heath L., Hartmann-Boyce J., CTAG taps team, p. 2257-2271.
- Risk, individual perception of risk and population health. Shield K.D., Gmel G., Mäkelä P., Probst C., Room R., Gmel G., et al., p. 2272-2273.
Lien : http://onlinelibrary.wiley.com/doi/10.1111/add.v112.12/issuetoc
Cote : Abonnement

Dépouillements

Ajouter le résultat à votre sélection
The experience of initiating injection drug use and its social context: a qualitative systematic review and thematic synthesis

The experience of initiating injection drug use and its social context: a qualitative systematic review and thematic synthesis

A. GUISE ; D. HORYNIAK ; J. MELO ; R. MCNEIL ; D. WERB | 2017
Dans Addiction (Vol.112, n°12, December 2017) Article : Périodique
Background and aim: Understanding the experience of initiating injection drug use and its social contexts is crucial to inform efforts to prevent transitions into this mode of drug consumption and support harm reduction. We reviewed and synthesi[...]
Plus d'info
Ajouter à la sélection Ajouter à la sélection
Who achieves low risk drinking during alcohol treatment? An analysis of patients in three alcohol clinical trials

Who achieves low risk drinking during alcohol treatment? An analysis of patients in three alcohol clinical trials

K. WITKIEWITZ ; M. R. PEARSON ; K. A. HALLGREN ; S. A. MAISTO ; C. R. ROOS ; M. KIROUAC ; A. D. WILSON ; K. S. MONTES ; N. HEATHER | 2017
Dans Addiction (Vol.112, n°12, December 2017) Article : Périodique
Background and aims: There is evidence that low-risk drinking is possible during the course of alcohol treatment and can be maintained following treatment. Our aim was to identify characteristics associated with low-risk drinking during treatmen[...]
Plus d'info
Ajouter à la sélection Ajouter à la sélection
Variation in cannabis potency and prices in a newly legal market: evidence from 30 million cannabis sales in Washington state

Variation in cannabis potency and prices in a newly legal market: evidence from 30 million cannabis sales in Washington state

R. SMART ; J. P. CAULKINS ; B. KILMER ; S. DAVENPORT ; G. MIDGETTE | 2017
Dans Addiction (Vol.112, n°12, December 2017) Article : Périodique
Aims: To (1) assess trends and variation in the market share of product types and potency sold in a legal cannabis retail market and (2) estimate how potency and purchase quantity influence price variation for cannabis flower. Design: Secondar[...]
Plus d'info
Ajouter à la sélection Ajouter à la sélection
Mapping medical marijuana: state laws regulating patients, product safety, supply chains and dispensaries, 2017

Mapping medical marijuana: state laws regulating patients, product safety, supply chains and dispensaries, 2017

S. B. KLIEGER ; A. GUTMAN ; L. ALLEN ; R. L. PACULA ; J. K. IBRAHIM ; S. BURRIS | 2017
Dans Addiction (Vol.112, n°12, December 2017) Article : Périodique
Aims: (1) To describe open source legal data sets, created for research use, that capture the key provisions of US state medical marijuana laws. The data document how state lawmakers have regulated a medicine that remains, under federal law, a S[...]
Plus d'info
Ajouter à la sélection Ajouter à la sélection
The association between personal income and smoking among adolescents: a study in six European cities

The association between personal income and smoking among adolescents: a study in six European cities

J. PERELMAN ; J. ALVES ; T. K. PFOERTNER ; I. MOOR ; B. FEDERICO ; M. A. G. KUIPERS ; M. RICHTER ; A. RIMPELA ; A. E. KUNST ; V. LORANT | 2017
Dans Addiction (Vol.112, n°12, December 2017) Article : Périodique
Aims: This study investigates the link between personal income and smoking among adolescents, and aims to answer the following questions: (i) to what extent is personal income related to smoking, independent of family socio-economic status (SES)[...]
Plus d'info
Ajouter à la sélection Ajouter à la sélection
open_link_url_notice Lien externe
Nouvelle recherche Votre compte

Contact

OFDT

69 rue de Varenne
75700 PARIS

Tel : (+33) 01 41 62 77 16

Accès rapides

  • L’établissement
  • Les partenaires
  • La lettre d’information

Avertissement

Toute inclusion dans la base documentaire ne vaut pas crédit scientifique de l'OFDT

Contact

OFDT

69 rue de Varenne
75700 PARIS

Tel : (+33) 01 41 62 77 16

Accès rapides

  • L’établissement
  • Les partenaires
  • La lettre d’information

Avertissement

Toute inclusion dans la base documentaire ne vaut pas crédit scientifique de l'OFDT

Suivez-nous

  • Traitement des données personnelles
  • Mentions légales
  • Plan du site